{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:55:03Z","timestamp":1789761303264,"version":"4.0.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.mce.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T05:22:02Z","timestamp":1378876922000},"page":"46-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors"],"prefix":"10.1016","volume":"386","author":[{"given":"Jessica","family":"Costa-Guda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-4608(98)00049-1","article-title":"Comparative genomic hybridization analysis of human parathyroid tumors","volume":"106","author":"Agarwal","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0005","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/1097-0142(19820115)49:2<388::AID-CNCR2820490230>3.0.CO;2-F","article-title":"Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer","volume":"49","author":"Aldinger","year":"1982","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10689-012-9520-z","article-title":"Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes","volume":"11","author":"Andreasson","year":"2012","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.mce.2013.09.005_b0025","unstructured":"Apel, R.L., Asa, S.L., 2002. The parathyroid glands. In: LiVolsi, V., Asa, S. (Eds.), Endocrine Pathology. Churchill Livingstone, Philadelphia, pp. 103\u2013147."},{"issue":"6","key":"10.1016\/j.mce.2013.09.005_b0030","first-page":"543","article-title":"The cyclin D1\/PRAD1 oncogene in human neoplasia","volume":"43","author":"Arnold","year":"1995","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.mce.2013.09.005_b0035","doi-asserted-by":"crossref","unstructured":"Arnold, A., Marx, S.J., 2008. Familial hyperparathyroidism. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, pp. 361\u2013366.","DOI":"10.1002\/9780470623992.ch76"},{"issue":"18","key":"10.1016\/j.mce.2013.09.005_b0040","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2005.05.064","article-title":"Cyclin D1 in breast cancer pathogenesis","volume":"23","author":"Arnold","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0045","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/MCB.01764-06","article-title":"p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors","volume":"27","author":"Bai","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0055","first-page":"154","article-title":"Parathyroid carcinoma, adenoma and hyperplasia in a case of chronic renal insufficiency on dialysis","volume":"18","author":"Berland","year":"1982","journal-title":"Clin. Nephrol."},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jc.2006-1197","article-title":"Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors","volume":"92","author":"Bjorklund","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.mce.2013.09.005_b0065","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1371\/journal.pmed.0040328","article-title":"An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/beta-catenin signaling","volume":"4","author":"Bjorklund","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.mce.2013.09.005_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-7-53","article-title":"Stabilizing mutation of CTNNB1\/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients","volume":"7","author":"Bjorklund","year":"2008","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","article-title":"Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours","volume":"64","author":"Bradley","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0080","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0085","first-page":"868","article-title":"Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia","volume":"85","author":"Brown","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2265.2004.01995.x","article-title":"Reduced p18INK4c, p21CIP1\/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism","volume":"60","author":"Buchwald","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0095","first-page":"701","article-title":"Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review)","volume":"15","author":"Buchwald","year":"2005","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0100","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/endo-117-5-2114","article-title":"1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture","volume":"117","author":"Cantley","year":"1985","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.mce.2013.09.005_b0105","first-page":"2960","article-title":"Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism","volume":"83","author":"Carling","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0115","first-page":"2255","article-title":"Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors","volume":"83","author":"Carling","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0120","first-page":"2000","article-title":"Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism","volume":"85","author":"Carling","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.mce.2013.09.005_b0110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0039-6060(03)00422-7","article-title":"Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas","volume":"134","author":"Carling","year":"2003","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.mce.2013.09.005_b0125","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/gcc.20911","article-title":"Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family","volume":"50","author":"Cascon","year":"2011","journal-title":"Genes Chromosom. Cancer"},{"issue":"6","key":"10.1016\/j.mce.2013.09.005_b0145","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1359\/jbmr.1999.14.6.878","article-title":"No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas","volume":"14","author":"Cetani","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.mce.2013.09.005_b0140","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","article-title":"Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?","volume":"156","author":"Cetani","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/ERC-09-0147","article-title":"Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas","volume":"17","author":"Cetani","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"issue":"5311","key":"10.1016\/j.mce.2013.09.005_b0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0160","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1210\/jc.2006-2554","article-title":"Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"92","author":"Costa-Guda","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.09.005_b0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-7-8","article-title":"Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas","volume":"7","author":"Costa-Guda","year":"2007","journal-title":"BMC Endocr. Disord."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0170","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.09.005_b0165","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-013-9903-4","article-title":"Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins","author":"Costa-Guda","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2013.09.005_b0175","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-013-0147-9","article-title":"Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas","author":"Costa-Guda","year":"2013","journal-title":"Horm. Cancer"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0185","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","article-title":"A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors","volume":"98","author":"Crabtree","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0190","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.mce.2013.09.005_b0195","first-page":"1320","article-title":"P53 abnormalities in human parathyroid carcinoma","volume":"78","author":"Cryns","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.mce.2013.09.005_b0200","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","article-title":"Parathyroid tumors and related disorders","volume":"24","author":"DeLellis","year":"2011","journal-title":"Mod. Pathol."},{"issue":"17","key":"10.1016\/j.mce.2013.09.005_b0205","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1073\/pnas.89.17.8097","article-title":"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3","volume":"89","author":"Demay","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0002-9343(84)90447-9","article-title":"Parathyroid hyperplasia and carcinoma within one gland","volume":"77","author":"Desch","year":"1984","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.2011.04184.x","article-title":"Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism","volume":"76","author":"Domingues","year":"2012","journal-title":"\u2217\u2217\u2217Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0220","first-page":"169","article-title":"Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors","volume":"11","author":"Erickson","year":"1998","journal-title":"Mod. Pathol."},{"issue":"8","key":"10.1016\/j.mce.2013.09.005_b0230","first-page":"2627","article-title":"Alterations of the MEN1 gene in sporadic parathyroid tumors","volume":"83","author":"Farnebo","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.mce.2013.09.005_b0225","first-page":"3775","article-title":"Alternative genetic pathways in parathyroid tumorigenesis","volume":"84","author":"Farnebo","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.mce.2013.09.005_b0235","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/MCB.20.16.6147-6158.2000","article-title":"Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity","volume":"20","author":"Franklin","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.mce.2013.09.005_b0240","first-page":"3048","article-title":"Recessive transmission of a multiple endocrine neoplasia syndrome in the rat","volume":"62","author":"Fritz","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2013.09.005_b0245","doi-asserted-by":"crossref","unstructured":"Georgitsi, M., XXXX. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Pract. Res. Clin. Endocrinol. Metab. 24(3), 425\u2013437.","DOI":"10.1016\/j.beem.2010.01.001"},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0250","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.mce.2013.09.005_b0265","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","article-title":"Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance","volume":"91","author":"Guarnieri","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0260","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/jc.2008-2430","article-title":"Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years","volume":"95","author":"Guarnieri","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-011-9558-y","article-title":"A rare S33C mutation of CTNNB1 encoding beta-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort","volume":"41","author":"Guarnieri","year":"2012","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0270","first-page":"349","article-title":"Concurrent primary parathyroid hyperplasia and parathyroid carcinoma","volume":"107","author":"Haghighi","year":"1983","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0275","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2265.2010.03830.x","article-title":"Lack of S37A CTNNB1\/beta-catenin mutations in a Swedish cohort of 98 parathyroid adenomas","volume":"73","author":"Haglund","year":"2010","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0280","first-page":"103","article-title":"Absence of p53 point mutations in parathyroid adenoma and carcinoma","volume":"78","author":"Hakim","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0285","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1677\/ERC-09-0082","article-title":"Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia","volume":"16","author":"Harding","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0290","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng1295-389","article-title":"A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"11","author":"Ho","year":"1995","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.mce.2013.09.005_b0300","first-page":"3107","article-title":"Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors","volume":"80","author":"Hosokawa","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0310","first-page":"1736","article-title":"Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study","volume":"81","author":"Hsi","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.mce.2013.09.005_b0315","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.pas.0000166368.68459.99","article-title":"Allelic loss in parathyroid neoplasia can help characterize malignancy","volume":"29","author":"Hunt","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0320","first-page":"463","article-title":"Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas","volume":"20","author":"Ikeda","year":"2002","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0325","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/path.1692","article-title":"Wnt signalling and the mechanistic basis of tumour development","volume":"205","author":"Ilyas","year":"2005","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0330","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0335","first-page":"481","article-title":"Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas","volume":"34","author":"Juhlin","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0340","doi-asserted-by":"crossref","first-page":"e9472","DOI":"10.1371\/journal.pone.0009472","article-title":"Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours","volume":"5","author":"Juhlin","year":"2010","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.mce.2013.09.005_b0345","doi-asserted-by":"crossref","first-page":"16758","DOI":"10.1074\/jbc.M110.210120","article-title":"Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein","volume":"286","author":"Kang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0350","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/00313020410001671957","article-title":"The significance of the Wnt pathway in the pathology of human cancers","volume":"36","author":"Karim","year":"2004","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0355","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.4203","article-title":"Complete genomic landscape of a recurring sporadic parathyroid carcinoma","volume":"230","author":"Kasaian","year":"2013","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0360","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","article-title":"HRPT2 mutational analysis of typical sporadic parathyroid adenomas","volume":"90","author":"Krebs","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0365","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9440(10)64568-3","article-title":"Patterns of chromosomal imbalances in parathyroid carcinomas","volume":"157","author":"Kytola","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.mce.2013.09.005_b0370","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"issue":"22","key":"10.1016\/j.mce.2013.09.005_b0375","first-page":"8022","article-title":"Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism","volume":"63","author":"Libutti","year":"2003","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.mce.2013.09.005_b0380","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.0710725105","article-title":"The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene","volume":"105","author":"Lin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0385","doi-asserted-by":"crossref","first-page":"F1192","DOI":"10.1152\/ajprenal.00360.2009","article-title":"Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology","volume":"297","author":"Meir","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5307","key":"10.1016\/j.mce.2013.09.005_b0390","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC","volume":"275","author":"Morin","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"issue":"6318","key":"10.1016\/j.mce.2013.09.005_b0400","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/350512a0","article-title":"A novel cyclin encoded by a bcl1-linked candidate oncogene","volume":"350","author":"Motokura","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mce.2013.09.005_b0405","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1083\/jcb.16.2.379","article-title":"The cytology of the normal parathyroid glands of man and Virginia deer; a light and electron microscopic study with morphologic evidence of secretory activity","volume":"16","author":"Munger","year":"1963","journal-title":"J. Cell Biol."},{"issue":"1 Pt 1","key":"10.1016\/j.mce.2013.09.005_b0410","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0022-5347(17)57920-3","article-title":"A case of parathyroid carcinoma concurred with hyperplasia: an electron microscopic study","volume":"118","author":"Murayama","year":"1977","journal-title":"J. Urol."},{"issue":"26","key":"10.1016\/j.mce.2013.09.005_b0415","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0420","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0425","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum. Mutat."},{"issue":"10","key":"10.1016\/j.mce.2013.09.005_b0430","doi-asserted-by":"crossref","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","article-title":"Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas","volume":"97","author":"Newey","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0435","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02555137","article-title":"1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells","volume":"43","author":"Nygren","year":"1988","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.mce.2013.09.005_b0440","first-page":"1766","article-title":"Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas","volume":"83","author":"Palanisamy","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0445","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2012-4029","article-title":"Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas","volume":"98","author":"Pardi","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0450","first-page":"2711","article-title":"Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2","volume":"81","author":"Pausova","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.mce.2013.09.005_b0455","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"42","key":"10.1016\/j.mce.2013.09.005_b0460","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0465","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mce.2013.09.005_b0470","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-200201000-00014","article-title":"Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses","volume":"26","author":"Sakai","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"10.1016\/j.mce.2013.09.005_b0475","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1210\/jc.2006-1543","article-title":"Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas","volume":"91","author":"Samander","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0480","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/EP:11:3:243","article-title":"Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity","volume":"11","author":"Semba","year":"2000","journal-title":"Endocr. Pathol."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0485","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2265.2003.01814.x","article-title":"Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma","volume":"59","author":"Shattuck","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"18","key":"10.1016\/j.mce.2013.09.005_b0490","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.mce.2013.09.005_b0495","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","article-title":"The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway","volume":"96","author":"Shtutman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2013.09.005_b0500","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.07310.x","article-title":"Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate","volume":"73","author":"Silver","year":"1999","journal-title":"Kidney Int. Suppl."},{"issue":"6","key":"10.1016\/j.mce.2013.09.005_b0505","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"Silverberg","year":"1999","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0520","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/gcc.20895","article-title":"The DNA methylome of benign and malignant parathyroid tumors","volume":"50","author":"Starker","year":"2011","journal-title":"Genes Chromosome Cancer"},{"issue":"1\u20132","key":"10.1016\/j.mce.2013.09.005_b0510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm. Cancer"},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0515","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-012-9690-3","article-title":"Evidence of a stabilizing mutation of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"42","author":"Starker","year":"2012","journal-title":"Endocrine"},{"issue":"17","key":"10.1016\/j.mce.2013.09.005_b0525","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1101\/gad.870101","article-title":"Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily","volume":"15","author":"Steele-Perkins","year":"2001","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0530","doi-asserted-by":"crossref","first-page":"e46325","DOI":"10.1371\/journal.pone.0046325","article-title":"Genome-wide and locus specific alterations in CDC73\/HRPT2-mutated parathyroid tumors","volume":"7","author":"Sulaiman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2013.09.005_b0535","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1476-4598-9-294","article-title":"Aberrant WNT\/beta-catenin signaling in parathyroid carcinoma","volume":"9","author":"Svedlund","year":"2010","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0540","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.1210\/jc.2011-3136","article-title":"Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification","volume":"97","author":"Svedlund","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.mce.2013.09.005_b0545","first-page":"599","article-title":"Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas","volume":"56","author":"Tahara","year":"1996","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.mce.2013.09.005_b0550","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.mce.2013.09.005_b0555","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(01)00729-7","article-title":"Biallelic inactivation by somatic mutations of the MEN1 gene in sporadic parathyroid tumors","volume":"175","author":"Tanaka","year":"2002","journal-title":"Cancer Lett."},{"issue":"6726","key":"10.1016\/j.mce.2013.09.005_b0560","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","article-title":"Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells","volume":"398","author":"Tetsu","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.mce.2013.09.005_b9000","doi-asserted-by":"crossref","unstructured":"Thakker R. V., Multiple Endocrine Neoplasia Type 1 and MEN-X, Mol. Cell. Endocrinol, in this issue. Doi: 10.1016\/j.mce.2013.08.002","DOI":"10.1016\/j.mce.2013.08.002"},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0565","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism","volume":"62","author":"Tokumoto","year":"2002","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0570","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.mce.2013.09.005_b0575","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod. Pathol."},{"issue":"4901","key":"10.1016\/j.mce.2013.09.005_b0580","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.2565047","article-title":"Allelotype of colorectal carcinomas","volume":"244","author":"Vogelstein","year":"1989","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mce.2013.09.005_b0585","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/MCB.00654-07","article-title":"Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice","volume":"28","author":"Wang","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.mce.2013.09.005_b0590","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1007\/s00268-009-0022-6","article-title":"Molecular genetics of parathyroid disease","volume":"33","author":"Westin","year":"2009","journal-title":"World J. Surg."},{"issue":"7","key":"10.1016\/j.mce.2013.09.005_b0595","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","article-title":"Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression","volume":"24","author":"Woodard","year":"2005","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.mce.2013.09.005_b0600","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720713003675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720713003675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:55:08Z","timestamp":1715975708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720713003675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":121,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0303720713003675"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2013.09.005","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}